RNA loops that adopt the characteristic GNRA "tetraloop" fold are common in natural RNAs. We selected peptides that bind an example of this RNA loop motif using mRNA display. Starting with the RNA recognition domain from the N protein, we constructed libraries containing 150 and 1,600 different peptide sequences as mRNApeptide fusions and isolated those capable of high-affinity RNA binding. These selections have resulted in almost 20 different peptides that bind the same RNA loop with nanomolar affinity. Analysis of one peptide complex by fluorescence spectroscopy and NMR spectroscopy suggest a different binding mode from the wild-type peptide. Our work demonstrates that multiple, chemically and conformationally distinct solutions exist for a particular RNA recognition problem.
Introduction
The ability to construct high-affinity, high-specificity peptide ligands provides a means to target RNA molecules of interest. Genetic approaches have been developed to isolate novel arginine-rich RNA-binding peptides in vivo (1) (2) (3) . These systems allow selection in the context of living systems, but limit library sizes to a maximum of ~10 5 to 10 6 sequences, allowing only four residues to be searched exhaustively (20 4 = 1.6 x10 5 ).
In vitro selection experiments to isolate RNA-binding peptides have not been demonstrated. A totally in vitro approach affords precise control over the selection conditions and the ability to explore much larger libraries, enabling the isolation of rare sequences.
We sought to use in vitro selection to isolate peptides that bind RNA tetraloops.
The tetraloop fold is a common element in many functional RNAs, enhancing duplex stability and participating in tertiary folding interactions (4) (5) (6) . We developed mRNA display (also known as the mRNA-peptide fusion system) to perform in vitro selection of peptides and proteins (7) . In mRNA display, cycles are carried out entirely in vitro and libraries larger than 10 13 independent sequences can be constructed ( Figure 4 .1, (7-10)).
The arginine-rich peptide corresponding to the RNA-binding domain of the N protein served as a starting point for our experiments and libraries. This short peptide (22 amino acids) recognizes the boxB RNA hairpin with high affinity and specificity as a bent -helix (11) (12) (13) (14) . The hairpin contains a five-base RNA loop that adopts a tetraloop fold with one base extruded (15, 16) . Here, we have used mRNA display to isolate peptides that bind the boxBR RNA motif. In the selection cycle, a double-stranded DNA library containing randomized codons is transcribed, generating a pool of mRNA templates. These templates are then ligated to a flexible DNA oligonucleotide containing puromycin at its 3' end. Translation of these ligated templates in vitro produces peptides covalently attached via their C-terminus to the 3' end of their own message by way of a stable amide linkage a mRNA-peptide fusion. These fusions are then converted into cDNA/mRNA hybrid fusions by using reverse transcriptase and subjected to selection on an affinity matrix. (b) Constructs used. N (1-22, amino acid sequence shown) binds to boxB as a bent -helix.
Results and Discussion

Peptide Fusion Binding
It was unclear a priori whether an RNA-binding peptide would be functional as either an mRNA-peptide or cDNA/mRNA-peptide fusion. We synthesized mRNApeptide fusions containing the N RNA binding domain (17) (Figure 4 .1B) and tested the ability of these molecules to bind an immobilized RNA target. (Figure 4 .2) shows that both the mRNA-peptide fusion and the cDNA/mRNA-peptide fusion specifically bind the boxBR RNA target. These assays demonstrate that a significant fraction of the desired complex can be isolated (30-60%) whereas little (1-5%) is retained to noncognate biotinylated RNA targets (Rev Response Element, RRE; U1 RNA hairpin loop II, U1).
In Vitro Selection of N Peptides
We designed two selections of increasing complexity to test our ability to isolate novel tetraloop-binding peptides. In selection 1, we randomized positions 6 and 7 of the wild-type construct (R6X, R7X, henceforth R67X). Previous mutagenesis and structural work indicated a single sequence, containing arginine at both positions (R6 and R7, henceforth R6R7), should be optimal for binding (1, 13) . The cassette contained 150 different amino acid combinations, only one of which was R6R7, and was designed such that the R6R7 sequence could be recognized and cut by the restriction enzyme NgoM IV (Figure 4 .3). We performed selection 1 (one round), three times in parallel, using increasing concentrations of competitor yeast tRNA to provide high stringency selection. Selection under stringent conditions is expected to increase the enrichment of functional sequences (18) (19) (20) .
Restriction analysis by NgoM IV indicated that a majority (>85%) of the selected clones contained R6R7 when 5 mg/mL tRNA competitor was used (Figure 4 .3).
Sequencing of clones selected under these conditions showed that 8/11 (72%) contained R6R7 (Figure 4 .4) and 50% of other sequences contained R7, expected to be the more important of the two positions (1). Thus, increased competitor allowed good enrichment (50-to 150-fold per round) without forcing us to make the target the limiting reagent (21) .
In selection 2 ( Figure 4 .5A, library 2) we randomized positions 7, 14, and 15, for a total of 1,600 possible combinations. In the wild-type N/boxBR complexes, residues 14 and 15 lie at the RNA-peptide interface (15, 16) and are important for binding (1, 14) .
After four rounds of selection, pool binding was similar to the wild-type sequence ( 
Characterization of the E14R15-boxB Complex
Peptide affinities were determined by fluorescence titration against 2-aminopurine (2AP) labeled boxBR. 2-aminopurine is a fluorescent nucleoside analog of adenine that has been previously substituted in RNA (23) . Peptides corresponding to wild-type N(1-22) and E14R15 were constructed synthetically and titrated against boxBR labeled at position 7 (2AP-7). Both peptides bind with high affinity to the target site (1.0 nM vs. 8.5 nM for wild-type and E14R15, respectively, Table 4 .1). The difference is small considering that a single change of K14 to A14 results in loss of more than 2 kcal/mol (>30-fold) (13) . The charge reversal of glutamic acid for lysine at position 14 is puzzling and may result from favorable interaction of glutamic acid with the helix dipole of residues 12-22 (24, 25) . quenching has been attributed to increased stacking, while fluorescence enhancement is attributed to increased exposure to aqueous solvent (23) . Quenching of 2AP in the N (1-22)/boxBR complex is expected, as W18 stacks on position 7 (15, 16) and tryptophan fluorescence is quenched in the complex (13) , and see below). Binding isotherms for K14Q15 (wild-type) N peptide (circles) and E14R15 peptide (squares). The E14R15 peptide was added to 2AP-7 labeled boxB RNA resulting in an increase in fluorescence. Addition of wild-type peptide to 2AP-7 labeled RNA results in an initial decrease, followed by a gradual increase in fluorescence because of tryptophan fluorescence.
We also investigated tryptophan fluorescence in the E14R15 complex. shows that addition of boxB RNA to wild-type peptide results in a dramatic decrease in W18 fluorescence, as reported previously (13) . However, addition of boxB RNA to the E14R15 peptide results in an increase of W18 fluorescence by ~10% relative to the unbound peptide. Taken together, these data imply that W18 is less stacked on adenine 7
in the E14R15 complex.
One-and two-dimensional NMR of the N/boxBR complexes provide information about the structure of both the bound peptide and RNA. Binding of the wild-type peptide results in a ~ 1 p.p.m. upfield shift of the Trp indole proton relative to the unbound peptide because of ring current effects in the stacked state (15, 16) . However, in the E14R15 complex, W18 is unshifted, indicating that it is not stacked in the complex (Figure 4.8) ; the chemical shift of the E14R15 W18 indole proton is similar to that of the Neither peptide shows any appreciable structure in the absence of RNA as judged by circular dichroism (CD) (Figure 4.10) . The difference spectra of the complexes indicate that both peptides fold into -helices when boxBR RNA is added (Figure 4.10) .
Although globally similar, the two complexes display differences in regions indicative of peptide folding (200-225 nm) and RNA folding (260-300 nm). E14R15 is somewhat less helical than the wild-type peptide. The biophysical data described above suggest that the E14R15 complex with boxB is similar in many respects to the wild-type complex. First, the E14R15 peptide binds with near wild-type affinity and folds into an -helix upon RNA binding. In the bound structure, the RNA and the N-terminal region of E14R15 are structurally similar to the wild-type. However, the tryptophan in the E14R15 complex does not stack on the RNA, and therefore the C-terminus of E14R15 is most likely in a different conformation than in the wild-type structure. This change in structure could disrupt native contacts between residues 16-22 of the E14R15 peptide and the RNA; the loss of the W18-RNA stacking interaction results in a loss of more than 2 kcal/mol of binding free energy (13) . We synthesized two model peptides, N (1-11) and E14R15 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) , to address the role of the residues between positions 13 and 22. The E14R15 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) peptide reveals that addition of R15 cannot be the sole feature that confers low nanomolar binding to the selected peptides. Adding the sequence containing E14R15 to the N (1-11) peptide confers only a 3-to 5-fold enhancement in K d , a G° of 0.7 to 1.0 kcal/mol ( 15) ). This result indicates that the amino acids between positions 16 and 22 contribute ~3 kcal/mol of binding free energy to the interaction.
Conclusions
Our results demonstrate that high-affinity RNA ligands may be isolated using mRNA display. Starting with the RNA binding domain of N, we isolated nearly 20 peptides that retain the ability to bind the boxB RNA. A non-wild-type consensus, containing arginine at position 15, emerges in the selected peptides leading to the question of why nature did not select for R15 in the N peptide. Perhaps the E14R15 peptide suggests a potential answer: while the E14R15 peptide possesses similar affinity to the wild-type, W18 is not stacked in the complex suggesting a different structure in the C-terminus of the peptide. It is interesting that a change of only two amino acids results in such a dramatic change in structure, and this structural change has little affect on binding affinity. Future experiments will address several of these issues. These data are consistent with a model where RNA-peptide interactions are highly context dependent.
In that vein, the combinatorial approach we have used provides a powerful design strategy for interactions where rules may be idiosyncratic at best.
Materials and Methods
Construction of Fusion Template
Templates and constructs used to assay fusion binding (Figure 4.2) correspond to the Nmyc construct described previously (17) . 
Binding Analysis
Selection Experiments
The library 1 and library 2 selection rounds were carried out essentially as described (17), except that the samples were desalted by ultrafiltration (YM-30, Millipore) and not gel purified after transcription. 
Restriction Digest and Quantitation
Quantitation by Affinity Precipitation
Peptides for each clone were produced by 35 Fluorescence measurements were performed essentially as in Lacourciere et al. (23) , with excitation and emission wavelengths of 310 and 370 nm, respectively.
Concentrated peptide was added stepwise to a stirred solution of 20 nM to 800 nM 2AP-7
RNA hairpin and the temperature was maintained at 20°C.
CD Spectroscopy
Spectra were taken on an Aviv 62 DS CD spectrometer at 25°C. The samples contained 10 μM RNA and 10 μM peptide in 10 mM potassium phosphate buffer (pH 7.9). The spectra of the bound peptides were determined by subtracting the free RNA and excess free peptide spectra from the spectra of the complex.
NMR Sample Preparation
BoxBR 
NMR Spectroscopy
NMR spectra were collected at 25°C on a Varian INOVA 600-MHz spectrometer. A modified double gradient echo Watergate solvent-suppression pulse sequence was used to suppress the solvent peak (28) . Assignments were based on reported work (13, 15, 16) . 
Sequencing
Phosphorylation of Oligonucleotides
Reactions typically consisted of ~60 pmol of ( 32 -P)-ATP (NEN), 60 pmol of primer, and 1 μL (10 U) of polynucleotide kinase (NEB) in 25 μL of 1X kinase buffer (70 mM Tris-HCl, pH 7.6, 10 mM MgCl 2 , 5 mM DTT). Samples were incubated at 37 o C for 30 minutes followed by 10 minutes at 95 o C to kill the enzyme. 
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